Healthcare

The Q3 2026 Pharma Biotools Report provides an analysis of recent VC activity and includes a link to our proprietary market map of leading VC-backed companies in the space.

The Q3 2026 Medtech Report report provides an analysis of recent VC and PE activity and includes a market map of leading VC- and PE-backed companies in the space.

The Q3 2026 Healthcare Services Report provides in-depth analysis of industry trends and evolving PE investment strategies, including deals data and maps of key PE-backed companies and investors.

A Republican election sweep would drive defense spending to $1.5 trillion and accelerate M&A. Democrats winning would trigger AI hearings and QSBS tax scrutiny.

The Q3 2026 Biopharma Report provides an analysis of recent VC activity and includes a link to our proprietary market map of leading VC-backed companies in the space.

After decades spent on consolidating dentists and eye doctors, private equity took a shot at med spas and GLP-1 clinics. The first big exit test comes in 2027.

Our Medtech Public Comp Sheet tracks stock performances, valuations, and market caps of key publicly traded medtech companies.

Our Healthcare Services Public Comp Sheet tracks stock performances, valuations, and market caps of key publicly traded healthcare services companies.

The 37-location med-spa chain could hit the market as soon as 2027, testing buyer appetite in a market waiting for exits.

This analyst note examines the BCI market’s TAM expansion, Neuralink’s competitive positioning, and underappreciated investment opportunities in adjacent sectors such as surgical robotics and psychiatry.

Specialist healthcare funds that once beat the market by 12 points now lag it, even as capital floods in.

The H1 2026 Healthcare Funds Report offers a comprehensive guide to healthcare and life sciences specialist managers across both private equity and venture capital.

The Q2 2026 Pharma Biotools Report provides an analysis of recent VC activity and includes a link to our proprietary market map of leading VC-backed companies in the space.

Once-hot sectors like dentistry and veterinary services are running short on large buyers and clean rollup integrations.

The Q2 2026 Pharma Services Report provides in-depth analysis of industry trends and evolving PE investment strategies, including deals data and maps of key PE-backed companies and investors.

The H1 2026 Healthcare IT PE Update highlights recent PE deal activity and dominant trends in healthcare IT.

The Q2 2026 Healthcare Services Report provides in-depth analysis of industry trends and evolving PE investment strategies, including deals data and maps of key PE-backed companies and investors.

The Q2 2026 Medtech Report report provides an analysis of recent VC and PE activity and includes a market map of leading VC- and PE-backed companies in the space.